Roles of CD48 in regulating immunity and tolerance
Open accessThe DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
CD48, a member of the signaling lymphocyte activation molecule family, participates in adhesion and activation of immune cells. Although constitutively expressed on most hematopoietic cells, CD48 is upregulated on subsets of activated cells. CD48 can have activating roles on T cells, antigen presenting cells and granulocytes, by binding to CD2 or bacterial FimH, and through cell intrinsic effects. Interactions between CD48 and its high affinity ligand CD244 are more complex, with both stimulatory and inhibitory outcomes. CD244:CD48 interactions regulate target cell lysis by NK cells and CTLs, which are important for viral clearance and regulation of effector/memory T cell generation and survival. Here we review roles of CD48 in infection, tolerance, autoimmunity, and allergy, as well as the tools used to investigate this receptor. We discuss stimulatory and regulatory roles for CD48, its potential as a therapeutic target in human disease, and current challenges to investigation of this immunoregulatory receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Self-citationBlackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062 · cited 2×
“CD244 is highly expressed on dysfunctional CD8+ T cells in chronic infection and cancer models [98].”
The Immunological Genome Project: networks of gene expression in immune cells
The Immunological Genome Project Consortium, Heng, T. S. P., Painter, M. W., Elpek, K., Lukacs-Kornek, V., Mauermann, N., Turley, S. J., Koller, D., Kim, F. S., Wagers, A. J., et al. (2008) · Nature Immunology · doi:10.1038/ni1008-1091 · Cited by 1,864
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Structural and Functional Roles of Glycosyl-Phosphatidylinositol in Membranes
Low, M. G., & Saltiel, A. R. (1988) · Science · doi:10.1126/science.3276003 · Cited by 952
Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., et al. (1998) · Nature · doi:10.1038/26683 · Cited by 943
Self-citationGPI-Anchored Cell-Surface Molecules Complexed to Protein Tyrosine Kinases
Štefanová, I., Hořejši, V., Ansotegui, I. J., Knapp, W., & Stockinger, H. (1991) · Science · doi:10.1126/science.1719635 · Cited by 826
Caveolae, DIGs, and the dynamics of sphingolipid—cholesterol microdomains
Harder, T., & Simons, K. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80030-0 · Cited by 779
SLAM Family Receptors and SAP Adaptors in Immunity
Cannons, J. L., Tangye, S. G., & Schwartzberg, P. L. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101302 · Cited by 497 · cited 2×
“The SLAM family (SLAMF) includes nine cell surface receptors, which participate in diverse aspects of immune function including costimulation, cytokine production, and cytotoxicity [1,2].”
X-Linked Lymphoproliferative Disease
Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J.-Y., Biassoni, R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.337 · Cited by 477
Polygenic control of susceptibility to murine systemic lupus erythematosus
Morel, L., Rudofsky, U. H., Longmate, J. A., Schiffenbauer, J., & Wakeland, E. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90100-7 · Cited by 471
2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48
Brown, M. H., Boles, K., Anton van der Merwe, P., Kumar, V., Mathew, P. A., & Neil Barclay, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2083 · Cited by 415
The structure and ligand interactions of CD2: implications for T-cell function
Davis, S. J., & van der Merwe, P. A. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80617-7 · Cited by 391 · cited 3×
“Encoded on chromosome 1 in mice and 1q23 in humans [3,4], the SLAM family includes CD48 (SLAMF2, BLAST-1) [5], a glycosylphosphatidylinositol (GPI) linked protein constitutively expressed on the surface of nearly all hematopoietic cells.”
Funk, J. L., Cordaro, L. A., Wei, H., Benjamin, J. B., & Yocum, D. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci728 · Cited by 332
Involvement of Cellular Caveolae in Bacterial Entry into Mast Cells
Shin, J.-S., Gao, Z., & Abraham, S. N. (2000) · Science · doi:10.1126/science.289.5480.785 · Cited by 323 · cited 3×
“Onmast cells, FimH binding to CD48 can trigger the mast cell TNFα response [106] and phagocytosis [70,107].”
Morel, L., Blenman, K. R., Croker, B. P., & Wakeland, E. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1787 · Cited by 317
Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic
Baorto, D. M., Gao, Z., Malaviya, R., Dustin, M. L., van der Merwe, A., Lublin, D. M., & Abraham, S. N. (1997) · Nature · doi:10.1038/39376 · Cited by 303
Rigby, M. R., Harris, K. M., Pinckney, A., DiMeglio, L. A., Rendell, M. S., Felner, E. I., Dostou, J. M., Gitelman, S. E., Griffin, K. J., Tsalikian, E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81722 · Cited by 291 · cited 2×
“In a recent description of trials initiated before the drug was discontinued, alefacept showed positive effects in preserving pancreatic beta cell function when administered in early onset type 1 diabetes [135,136].”
Garni-Wagner, B. A., Purohit, A., Mathew, P. A., Bennett, M., & Kumar, V (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.1.60 · Cited by 288
Howard, F. D., Ledbetter, J. A., Wong, J., Bieber, C. P., Stinson, E. B., & Herzenberg, L. A. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.6.2117 · Cited by 276
Engagement of GPI-Linked CD48 Contributes to TCR Signals and Cytoskeletal Reorganization
Moran, M., & Miceli, M. C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80644-5 · Cited by 267 · cited 6×
“The authors proposed amodelwhereGPI-linked CD48 interacts in ciswithCD2 to efficiently bring Lck and LAT to the TCR/CD3 complex, and thereby facilitate TCR signaling (Fig.”
InfluentialAssociation of Extensive Polymorphisms in the SLAM/CD2 Gene Cluster with Murine Lupus
Wandstrat, A. E., Nguyen, C., Limaye, N., Chan, A. Y., Subramanian, S., Tian, X.-H., Yim, Y.-S., Pertsemlidis, A., Garner, H. R., Morel, L., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.10.009 · Cited by 258
Malaviya, R., Gao, Z., Thankavel, K., van der Merwe, P. A., & Abraham, S. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8110 · Cited by 255
Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion.
Dustin, M. L., Sanders, M. E., Shaw, S., & Springer, T. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.3.677 · Cited by 253
Poy, F., Yaffe, M. B., Sayos, J., Saxena, K., Morra, M., Sumegi, J., Cantley, L. C., Terhorst, C., & Eck, M. J. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80206-3 · Cited by 241
Self-citationRegulation of B Cell Tolerance by the Lupus Susceptibility Gene Ly108
Kumar, K. R., Li, L., Yan, M., Bhaskarabhatla, M., Mobley, A. B., Nguyen, C., Mooney, J. M., Schatzle, J. D., Wakeland, E. K., & Mohan, C. (2006) · Science · doi:10.1126/science.1125893 · Cited by 232
Chamian, F., Lowes, M. A., Lin, S.-L., Lee, E., Kikuchi, T., Gilleaudeau, P., Sullivan-Whalen, M., Cardinale, I., Khatcherian, A., Novitskaya, I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409569102 · Cited by 221
CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.
Kato, K., Koyanagi, M., Okada, H., Takanashi, T., Wong, Y. W., Williams, A. F., Okumura, K., & Yagita, H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1241 · Cited by 220 · cited 1×
“The costimulatory function of CD48 was first identified by the ability of cross-linked anti-CD48 mAb to augment anti-CD3-induced proliferation of murine T cells; stimulation through CD48 alone was not sufficient to induce proliferation [7].”
Shlapatska, L. M., Mikhalap, S. V., Berdova, A. G., Zelensky, O. M., Yun, T. J., Nichols, K. E., Clark, E. A., & Sidorenko, S. P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5480 · Cited by 217
Rigby, M. R., DiMeglio, L. A., Rendell, M. S., Felner, E. I., Dostou, J. M., Gitelman, S. E., Patel, C. M., Griffin, K. J., Tsalikian, E., Gottlieb, P. A., et al. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70111-6 · Cited by 209 · cited 1×
“In a recent description of trials initiated before the drug was discontinued, alefacept showed positive effects in preserving pancreatic beta cell function when administered in early onset type 1 diabetes [135,136].”
Lee, K.-M., McNerney, M. E., Stepp, S. E., Mathew, P. A., Schatzle, J. D., Bennett, M., & Kumar, V. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031989 · Cited by 208
van der Merwe, P. A., Barclay, A. N., Mason, D. W., Davies, E. A., Morgan, B. P., Tone, M., Krishnam, A. K. C., Ianelli, C., & Davis, S. J. (1994) · Biochemistry · doi:10.1021/bi00199a043 · Cited by 204 · cited 1×
“However, humans (unlike mice) also have the CD58 (LFA-3) gene, which shares homologywith CD48 and is the high affinity ligand for CD2 (Kd ~ 9–22 μM) [73,74].”
Mathew, P. A., Garni-Wagner, B. A., Land, K., Takashima, A., Stoneman, E., Bennett, M., & Kumar, V (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5328 · Cited by 202
The role of the CD58 locus in multiple sclerosis
De Jager, P. L., Baecher-Allan, C., Maier, L. M., Arthur, A. T., Ottoboni, L., Barcellos, L., McCauley, J. L., Sawcer, S., Goris, A., Saarela, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813310106 · Cited by 197
Ward, J., Bonaparte, M., Sacks, J., Guterman, J., Fogli, M., Mavilio, D., & Barker, E. (2007) · Blood · doi:10.1182/blood-2006-06-028175 · Cited by 190 · cited 1×
“For example, CD48 and NTB-A (SLAMF6) are downregulated on HIV-infected T cell blasts, which could potentially limit the ability of NK and CD8+ T cells to lyse infected target cells [141].”
Bygrave, A. E., Rose, K. L., Cortes-Hernandez, J., Warren, J., Rigby, R. J., Cook, H. T., Walport, M. J., Vyse, T. J., & Botto, M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020243 · Cited by 186
Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates
Weaver, T. A., Charafeddine, A. H., Agarwal, A., Turner, A. P., Russell, M., Leopardi, F. V., Kampen, R. L., Stempora, L., Song, M., Larsen, C. P., et al. (2009) · Nature Medicine · doi:10.1038/nm.1993 · Cited by 184
Cutting Edge: Identification of the 2B4 Molecule as a Counter-Receptor for CD48
Latchman, Y. E., McKay, P. F., & Reiser, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5809 · Cited by 180 · cited 1×
“The authors proposed that increased adhesion could be responsible for the increased stimulatory effect since they observed increased T cell-APC conjugates [8].”
Identification of the 2B4 molecule as a counter-receptor for CD48.
Latchman, Y. E., McKay, P. F., & Reiser, H. (1998) · PubMed · Cited by 170
Punnonen, J., Cocks, B. G., Carballido, J. M., Bennett, B., Peterson, D., Aversa, G., & Vries, J. E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.993 · Cited by 166
The SLAM and SAP Gene Families Control Innate and Adaptive Immune Responses
Calpe, S., Wang, N., Romero, X., Berger, S. B., Lanyi, A., Engel, P., & Terhorst, C. (2008) · Advances in Immunology · doi:10.1016/s0065-2776(08)00004-7 · Cited by 164 · cited 2×
“The SLAM family (SLAMF) includes nine cell surface receptors, which participate in diverse aspects of immune function including costimulation, cytokine production, and cytotoxicity [1,2].”
Self-citationRelease of GPI‐anchored membrane proteins by a cell‐associated GPI‐specific phospholipase D.
Metz, C. N., Brunner, G., Choi-Muira, N. H., Nguyen, H., Gabrilove, J. L., Caras, I. W., ALTSZULER, N., Rifkin, D. B., Wilson, E. L., & Davitz, M. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06438.x · Cited by 163 · cited 1×
“It is not known how the soluble form of CD48 is generated, but GPI-linked molecules are susceptible to cleavage by phospholipases such as phospholipase C and phospholipase D [53,54].”
Baranzini, S. E., Khankhanian, P., Patsopoulos, N. A., Li, M., Stankovich, J., Cotsapas, C., Søndergaard, H. B., Ban, M., Barizzone, N., Bergamaschi, L., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.019 · Cited by 163 · cited 2×
“In a separate protein-interaction-network-based pathway analysis in MS, CD48 was among a small group of high confidence candidates [51].”
Mavaddat, N., Mason, D., Atkinson, P. D., Evans, E. J., Gilbert, R. J. C., Stuart, D. I., Fennelly, J. A., Barclay, A. N., Davis, S. J., & Brown, M. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004117200 · Cited by 161
Molecular Basis of the Dual Functions of 2B4 (CD244)
Chlewicki, L. K., Velikovsky, C. A., Balakrishnan, V., Mariuzza, R. A., & Kumar, V. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8159 · Cited by 150
SLAM-Family Receptors: Immune Regulators with or without SAP-Family AdaptorsPreprint
Veillette, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002469 · Cited by 149 · cited 2×
“Some studies suggest that signaling through EAT-2 promotes inhibitory effects, whereas signaling via SAP-Fyn promotes activation and target lysis [100].”
Tight Regulation of Memory CD8+ T Cells Limits Their Effectiveness during Sustained High Viral Load
West, E. E., Youngblood, B., Tan, W. G., Jin, H.-T., Araki, K., Alexe, G., Konieczny, B. T., Calpe, S., Freeman, G. J., Terhorst, C., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.017 · Cited by 144 · cited 3×
“While a functional role for CD244 in T cell exhaustion has been demonstrated in at least one model of infection [99], it is not yet clear if or how CD48 contributes to this phenotype.”
InfluentialSelf-citationWaggoner, S. N., Taniguchi, R. T., Mathew, P. A., Kumar, V., & Welsh, R. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41264 · Cited by 143 · cited 1×
“found that CD244−/−mice were more susceptible to chronic infection with lymphocyte choriomeningitis virus, due to enhanced NKmediated lysis of activated CD44+ CD8+ T effectors [103].”
Martı́n, M., Ros, X. R., de la Fuente, M. Á., Tovar, V., Zapater, N., Esplugues, E., Pizcueta, P. M., Bosch, J., & Engel, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3668 · Cited by 137
Dual Function of the NK Cell Receptor 2B4 (CD244) in the Regulation of HCV-Specific CD8+ T Cells
Schlaphoff, V., Lunemann, S., Suneetha, P. V., Jaroszewicz, J., Grabowski, J., Dietz, J., Helfritz, F., Bektas, H., Sarrazin, C., Manns, M. P., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002045 · Cited by 132
Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn
Bloch‐Queyrat, C., Fondanèche, M., Chen, R., Yin, L., Relouzat, F., Veillette, A., Fischer, A., & Latour, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050449 · Cited by 124 · cited 1×
“This mechanism is supported by studies of NK cells lacking SAP or Fyn, which show defects in lysis of CD48+ targets [101].”
Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4
Schatzle, J. D., Sheu, S. U., Stepp, S. E., Mathew, P. A., Bennett, M., & Kumar, V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3870 · Cited by 123 · cited 1×
“The long form is inhibitory and the short form is stimulatory [12].”
2B4 (CD244) Is Expressed and Functional on Human Eosinophils
Munitz, A., Bachelet, I., Fraenkel, S., Katz, G., Mandelboim, O., Simon, H., Moretta, L., Colonna, M., & Levi‐Schaffer, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.110 · Cited by 121 · cited 1×
“Human eosinophils also express CD244 and SAP, and crosslinking CD244 results in production of eosinophil peroxidase, IFNγ and IL-4 [115].”
Palendira, U., Low, C., Chan, A., Hislop, A. D., Ho, E. C., Phan, T. G., Deenick, E. K., Cook, M., Riminton, S., Choo, S., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001187 · Cited by 121 · cited 1×
“Similarly, SAPdeficient CD8+ T cells can be activated by most types of APCs, but fail to be activated by antigen-presenting B cells — and EBV selectively infects B cells [140].”
Arulanandam, A. R. N., Moingeon, P. E., Concino, M. F., Recny, M. A., Kato, K., Yagita∥, H., Koyasu, S., & Reinherz, E. L. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.5.1439 · Cited by 119 · cited 2×
“Similarly, in humans CD48 binds to CD2 with Kd ~ 100 μM [72], and to CD244 with Kd ~ 8 μM [71].”
Evolving role of 2B4/CD244 in T and NK cell responses during virus infection
Waggoner, S. N., & Kumar, V. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00377 · Cited by 116 · cited 1×
“It is not yet clear how CD48 levels on target cells influence cytotoxicity, as CD244:CD48 interactions have been shown to either enhance or inhibit cytotoxicity of NK and CD8+ T cells, depending on the context [142].”
Stulnig, T. M., Berger, M., Sigmund, T., Stockinger, H., Hořejšı́, V., & Waldhäusl, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19242 · Cited by 116 · cited 1×
“Further studies showed that CD48 physically interacts with Lck [89], and that CD48 crosslinking results in intracellular calcium flux in a cholesterol-dependent mechanism [90] and enhances IL-2 production and TCR signaling, shortening the time of TCR engagement necessary for human T cells to commit to IL-2 production…”
Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells.
Yagita∥, H., Nakamura, T., Karasuyama, H., & Okumura, K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.645 · Cited by 114
ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48
Ha, S. G., Ge, X. N., Bahaie, N. S., Kang, B. N., Rao, A., Rao, S. P., & Sriramarao, P. (2013) · Nature Communications · doi:10.1038/ncomms3479 · Cited by 111 · cited 2×
“diated degranulation in eosinophils [114]”
CD48-deficient mice have a pronounced defect in CD4 + T cell activation
González-Cabrero, J., Wise, C. J., Latchman, Y. E., Freeman, G. J., Sharpe, A. H., & Reiser, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1019 · Cited by 109 · cited 2×
“129] APCs are less stimulatory to WT T cells, when compared to WT APCs, in an allo-mixed lymphocyte reaction [10].”
Self-citationNovel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A
Li, S.-C., Gish, G. D., Yang, D., Coffey, A. J., Forman-Kay, J. D., Ernberg, I. T., Kay, L. E., & Pawson, T. J. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80080-9 · Cited by 108
Vaidya, S. V., Stepp, S. E., McNerney, M. E., Lee, J., Bennett, M., Lee, K., Stewart, C. L., Kumar, V., & Mathew, P. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.800 · Cited by 100
Romero, X., Benítez, D., March, S., Vilella, R., Miralpeix, M., & Engel, P. (2004) · Tissue Antigens · doi:10.1111/j.1399-0039.2004.00247.x · Cited by 94
Rocha-de-Souza, C. M., Berent-Maoz, B., Mankuta, D., Moses, A. E., & Levi-Schaffer, F. (2008) · Infection and Immunity · doi:10.1128/iai.00270-08 · Cited by 93 · cited 2×
“Blocking CD48 with an anti-CD48 mAb reduced the inflammatory responses of these cells [65], supporting a cell intrinsic role for CD48 in response to infection.”
FimH-mediated Escherichia coli K1 invasion of human brain microvascular endothelial cells
Khan, N. A., Kim, Y., Shin, S., & Kim, K. S. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00779.x · Cited by 90 · cited 1×
“coli K1 can bind to CD48 on cultured human brain microvascular endothelial cells, thereby promoting bacterial adhesion and inducing cellular changes in the endothelial cells that facilitate bacterial invasion [109].”
Cutting Edge: NTB-A Activates NK Cells via Homophilic Interaction
Flaig, R. M., Stark, S., & Watzl, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6524 · Cited by 86
Cao, E., Ramagopal, U. A., Fedorov, A. A., Fedorov, E. V., Yan, Q., Lary, J. W., Cole, J. L., Nathenson, S. G., & Almo, S. C. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.020 · Cited by 84
Ros, X. R., Zapater, N., Calvo, M., Kalko, S. G., de la Fuente, M. Á., Tovar, V., Ockeloen, C. W., Pizcueta, P. M., & Engel, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7033 · Cited by 82
Lee, K., Bhawan, S., Majima, T., Wei, H., Nishimura, M. I., Yagita∥, H., & Kumar, V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4881 · Cited by 81
CD48: A co-stimulatory receptor of immunity
Elishmereni, M., & Levi‐Schaffer, F. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.09.001 · Cited by 81
Möller, J., Lühmann, T., Chabria, M., Hall, H., & Vogel, V. (2013) · Scientific Reports · doi:10.1038/srep02884 · Cited by 81 · cited 16×
“FimH on E. coli K1 can bind to CD48 on cultured human brain microvascular endothelial cells, thereby promoting bacterial adhesion and inducing cellular changes in the endothelial cells that facilitate bacterial invasion [109].”
InfluentialCirculating CD2+ Monocytes Are Dendritic Cells
Crawford, K. D., Gabuzda, D. H., Pantazopoulos, V., Xu, J., Clement, C., Reinherz, E. L., & Alper, C. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5920 · Cited by 81
Selective targeting of T cell subsets: focus on alefacept – a remittive therapy for psoriasis
Krueger, G. G. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.4.431 · Cited by 79 · cited 1×
“CD58-Ig has multiple immunosuppressive effects on T cells, including depletion of memory cells and inhibition of T cell activation [132,133].”
Larochelle, A., Savona, M. R., Wiggins, M. A., Anderson, S., Ichwan, B., Keyvanfar, K., Morrison, S. J., & Dunbar, C. E. (2010) · Blood · doi:10.1182/blood-2009-03-212803 · Cited by 77 · cited 1×
“However, in humans CD48 is also found on neutrophils and other HSC types [61,62].”
Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety
Baldo, B. A. (2015) · Drug Safety · doi:10.1007/s40264-015-0285-9 · Cited by 77 · cited 1×
“Alefacept was used for treatment of plaque psoriasis [129] until the manufacturer discontinued production and sales in 2011, citing business needs and stating that this was not due to safety concerns [130, 131].”
Structure of CD84 provides insight into SLAM family function
Yan, Q., Malashkevich, V. N., Fedorov, A., Fedorov, E., Cao, E., Lary, J. W., Cole, J. L., Nathenson, S. G., & Almo, S. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703893104 · Cited by 76
Interacting mast cells and eosinophils acquire an enhanced activation state in vitro
Elishmereni, M., Bachelet, I., Efraim, A. H. N. B., Mankuta, D., & Levi‐Schaffer, F. (2012) · Allergy · doi:10.1111/all.12059 · Cited by 76 · cited 1×
“CD48 and CD244 can mediate interactions between eosinophils and mast cells in vitro, allowing eosinophils to costimulate IgE-mediated activation of mast cells [80].”
Responses to Microbial Challenges by SLAMF Receptors
van Driel, B., Liao, G., Engel, P., & Terhorst, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00004 · Cited by 76
Self-citationMilstein, O., Tseng, S.-Y., Starr, T., Llodrá, J., Nans, A., Liu, M., Wild, M. K., van der Merwe, P. A., Stokes, D. L., Reisner, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804756200 · Cited by 74
Staunton, D. E., Fisher, R. C., Beau, M. M. L., Lawrence, J. B., Barton, D. E., Francke, U., Dustin, M. L., & Thorley‐Lawson, D. A. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.3.1087 · Cited by 73 · cited 4×
“Encoded on chromosome 1 in mice and 1q23 in humans [3,4], the SLAM family includes CD48 (SLAMF2, BLAST-1) [5], a glycosylphosphatidylinositol (GPI) linked protein constitutively expressed on the surface of nearly all hematopoietic cells.”
InfluentialImmune evasion by oncogenic proteins of acute myeloid leukemia
Elias, S., Yamin, R., Golomb, L., Tsukerman, P., Stanietsky, N., Ben‐Yehuda, D., & Mandelboim, O. (2014) · Blood · doi:10.1182/blood-2013-09-526590 · Cited by 72
Chamian, F., Lin, S.-L., Lee, E., Kikuchi, T., Gilleaudeau, P., Sullivan-Whalen, M., Cardinale, I., Khatcherian, A., Novitskaya, I., Wittkowski, K. M., et al. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-27 · Cited by 71
Cloning, Expression, and Function of BLAME, a Novel Member of the CD2 Family
Kingsbury, G. A., Feeney, L. A., Nong, Y., Calandra, S. A., Murphy, C., Corcoran, J., Wang, Y., Das, M. R. P., Busfield, S. J., Fraser, C. C., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5675 · Cited by 68
Southern MS Genetics Consortium, Arthur, A. T., Armati, P. J., Bye, C., Heard, R. N., Stewart, G. J., Pollard, J. D., & Booth, D. R. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-17 · Cited by 66 · cited 1×
“Notably, CD58 expression also increases during remissions in MS patients [125,127].”
A novel isoform of the Ly108 gene ameliorates murine lupus
Keszei, M., Detre, C., Rietdijk, S. T., Muñoz, P., Ros, X. R., Berger, S. B., Calpe, S., Liao, G., Castro, W., Julien, A., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101653 · Cited by 66
Self-citationSchuhmachers, G., Ariizumi, K., Mathew, P. A., Bennett, M., Kumar, V. B., & Takashima, A. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12323533 · Cited by 65
CD48 Is an Allergen and IL-3-Induced Activation Molecule on Eosinophils
Munitz, A., Bachelet, I., Eliashar, R., Khodoun, M. V., Finkelman, F. D., Rothenberg, M. E., & Levi‐Schaffer, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.77 · Cited by 63 · cited 4×
“In the realm of allergy and asthma, CD48 serves as a biomarker for activated granulocytes and promotes granulocyte degranulation [64].”
InfluentialCarlucci, F., Cortés-Hernández, J., Fossati‐Jimack, L., Bygrave, A. E., Walport, M. J., Vyse, T. J., Cook, H. T., & Botto, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2352 · Cited by 62 · cited 1×
“For example, B6 congenic mice that carry the 129-derived version of chromosome 1 in the region containing the SLAM family genes spontaneously develop autoantibodies [110].”
CD48 as a novel molecular target for antibody therapy in multiple myeloma
Hosen, N., Ichihara, H., Mugitani, A., Aoyama, Y., Fukuda, Y., Kishida, S., Matsuoka, Y., Nakajima, H., Kawakami, M., Yamagami, T., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08941.x · Cited by 56 · cited 2×
“Multiple-myeloma Anti-human CD48 mAb depletes human-derived multiple-myeloma in mice [69] 15 S.”
CD48 on hematopoietic progenitors regulates stem cells and suppresses tumor formation
Boles, N. C., Lin, K., Lukov, G. L., Bowman, T. V., Baldridge, M. T., & Goodell, M. A. (2011) · Blood · doi:10.1182/blood-2010-12-322339 · Cited by 48 · cited 2×
“Aged CD48−/− mice had an increased incidence of lymphoma, which correlated with upregulated Pak1 activity in CD19+ tumor cells but not in CD19+ cells from the spleen [122].”
Sequential Cooperation of CD2 and CD48 in the Buildup of the Early TCR Signalosome
Muhammad, A., Schiller, H. B., Förster, F., Eckerstorfer, P., Geyeregger, R., Leksa, V., Zlabinger, G. J., Sibilia, M. C., Sonnleitner, A., Paster, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800691 · Cited by 45
Drbal, K., Moertelmaier, M., Holzhauser, C., Muhammad, A., Fuertbauer, E., Howorka, S., Hinterberger, M., Stockinger, H. S. J., & Schütz, G. J. (2007) · International Immunology · doi:10.1093/intimm/dxm032 · Cited by 45 · cited 1×
“found that CD48 becomes immobilized in the immune synapse of anti-CD3-stimulated T cells, while other GPI-linked proteins like CD59 did not [92].”
Crystal Structure and Binding Properties of the CD2 and CD244 (2B4)-binding Protein, CD48
Evans, E. J., Castro, M. A., O’Brien, R., Kearney, A., Walsh, H., Sparks, L. M., Tucknott, M. G., Davies, E., Carmo, A. M., van der Merwe, P. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601314200 · Cited by 42
The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation
Minai‐Fleminger, Y., Gangwar, R. S., Migalovich-Sheikhet, H., Seaf, M., Leibovici, V., Hollander, N., Feld, M., Moses, A. E., Homey, B., & Levi‐Schaffer, F. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12422 · Cited by 39 · cited 1×
“129] mice had reduced numbers of eosinophils and granulocytes in peritoneal lavage fluid, but no reduction in lymphocytes, when compared to WT mice [116].”
2B4 inhibits NK-cell fratricide
Taniguchi, R. T., Guzior, D. F., & Kumar, V. (2007) · Blood · doi:10.1182/blood-2007-02-076927 · Cited by 38 · cited 2×
“regulatory role for CD48:CD244 in limiting NK fratricide [18]”
Zarama, A., Pérez‐Carmona, N., Farré, D., Tomić, A., Borst, E. M., Messerle, M., Jonjić, S., Engel, P., & Angulo, A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004000 · Cited by 38 · cited 1×
“In murine cytomegalovirus (CMV) infection, the mucin-like protein m154 reduces CD48 expression on macrophages, which limits NK cellmediated control of viral infection [67].”
Wang, N., Calpe, S., Westcott, J. M., Castro, W., Ma, C., Engel, P., Schatzle, J. D., & Terhorst, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001974 · Cited by 36 · cited 1×
“found that EAT-2A and 2B deficiency in B6 mice resulted in a defect in CD244-dependent lysis by NK cells, whichwas in contrast to prior studies examining EAT-2A and 2B deficiency on the 129Sv genetic background [100,102] and may reflect polymorphisms in SLAM family members in the B6 and 129 strain backgrounds, and/or…”
Self-citationPig Embryonic Pancreatic Tissue as a Source for Transplantation in Diabetes
Tchorsh, D., Hecht, G., Aronovich, A., Shezen, E., Klionsky, Y. Z., Rosen, C., Bitcover, R., Eventov‐Friedman, S., Katchman, H., Cohen, S., et al. (2009) · Diabetes · doi:10.2337/db09-0112 · Cited by 34 · cited 3×
“Solid organ — islet Combination therapy with anti-CD48 mAb, FTY720 and anti-LFA-1mAb promotes pig islet allograft survival in mice [120]”
InfluentialCD58 polymorphisms associated with the risk of neuromyelitis optica in a Korean population
Kim, Y., Bae, J. S., Kim, H. J., & Shin, H. D. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-57 · Cited by 33 · cited 1×
“Two haplotypes and four alleles showed an association with NMO, by TaqMan analysis, but no functional studies were performed [128].”
The safety and efficacy of alefacept in the treatment of chronic plaque psoriasis.
Jenneck, C., & Novak, N. (2007) · PubMed · Cited by 33
CD48 Controls T-Cell and Antigen-Presenting Cell Functions in Experimental Colitis
Abadía‐Molina, A. C., Ji, H., Faubion, W. A., Julien, A., Latchman, Y. E., Yagita∥, H., Sharpe, A. H., Bhan, A. K., & Terhorst, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.009 · Cited by 30 · cited 4×
“Specifically, CD48−/− macrophages exhibited impaired TNFα and IL-12 production in response to LPS in vitro and stimulated WT T cells more poorly compared to WT peritoneal macrophages [111].”
InfluentialSelf-citationCD244 is expressed on dendritic cells and regulates their functions
Georgoudaki, A., Khodabandeh, S., Puiac, S., Persson, C. M., Larsson, M. K., Lind, M., Hammarfjord, O., Nabatti, T. H., Wallin, R. P. A., Yrlid, U., et al. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2014.124 · Cited by 30
Complex 2B4 Regulation of Mast Cells and Eosinophils in Murine Allergic Inflammation
Elishmereni, M., Fyhrquist, N., Gangwar, R. S., Lehtimäki, S., Alenius, H. T., & Levi‐Schaffer, F. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.280 · Cited by 28
Inhibition and Activation by CD244 Depends on CD2 and Phospholipase C-γ1
Clarkson, N. G., & Brown, M. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028209 · Cited by 28 · cited 2×
“In addition, CD2 on NK cells can compete with CD244 for binding to CD48 on target cells, thus providing additional influences on NK cell activation [16].”
Limaye, N., Belobrajdic, K., Wandstrat, A. E., Bonhomme, F., Edwards, S. V., & Wakeland, E. K. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364446 · Cited by 26 · cited 1×
“In contrast, numerous polymorphisms exist in the Ig domains of CD48 in wild mouse populations [49].”
O’Keeffe, M. S., Song, J.-H., Liao, G., Calisto, J. D., Halibozek, P. J., Mora, J. R., Bhan, A. K., Wang, N., Reinecker, H., & Terhorst, C. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.003 · Cited by 25 · cited 1×
“In a model of inflammatory colitis, CD244 on CD8+ intraepithelial lymphocytes was found to be critical for limiting cytotoxicity [97].”
Self-citationKeszei, M., Latchman, Y. E., Vanguri, V. K., Brown, D. R., Detre, C., Morra, M., Arancibia, C., Paul, E., Calpe, S., Castro, W., et al. (2011) · International Immunology · doi:10.1093/intimm/dxq465 · Cited by 24
Self-citationSimultaneous TCR and CD244 Signals Induce Dynamic Downmodulation of CD244 on Human Antiviral T Cells
Pacheco, Y., McLean, A. P., Rohrbach, J., Porichis, F., Kaufmann, D., & Kavanagh, D. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300435 · Cited by 22 · cited 1×
“In addition, CD244 expression on virus-specific CD8+ T cells decreased after simultaneous TCR and CD244 signaling, suggesting that binding to CD48 could influence CD244 expression [144].”
XLP 1 inhibitory effect by 2 B 4 does not affect DNAM ‐1 and NKG 2 D activating pathways in NK cells
Meazza, R., Tuberosa, C., Cetica, V., Falco, M., Loiacono, F., Parolini, S., Micalizzi, C., Moretta, A., Mingari, M. C., Moretta, L., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344312 · Cited by 22 · cited 1×
“Notably, EBV+ B cells do not express ligands for the activatingNK receptors DNAM-1 and NKG2a, rendering these cells particularly sensitive to CD244-mediated lysis by NK cells [139].”
Pérez‐Carmona, N., Farré, D., Martínez‐Vicente, P., Terhorst, C., Engel, P., & Angulo, A. (2015) · Journal of Virology · doi:10.1128/jvi.01296-15 · Cited by 20 · cited 1×
“Owl monkey CMV produces a soluble CD48 homolog, which can bind to CD244 and may function as a decoy receptor [68].”
Self-citationCD2–CD48 interactions promote interleukin-2 and interferon-γ synthesis by stabilizing cytokine mRNA
Musgrave, B. L., Watson, C. L., Haeryfar, S. M. M., Barnes, C. A., & Hoskin, D. W. (2004) · Cellular Immunology · doi:10.1016/j.cellimm.2004.06.006 · Cited by 17 · cited 1×
“The reduced target lysis could be rescued by addition of IL-2 [95], suggesting that CD48:CD2 costimulation may stabilize IL-2 mRNA [96].”
Gokhale, A. S., Sable, R. V., Walker, J. D., McLaughlin, L. D., Kousoulas, K. G., & Jois, S. D. S. (2015) · Biopolymers · doi:10.1002/bip.22692 · Cited by 14 · cited 3×
“Disease Animal model Effects of CD48 blockade or deficiency Refs Autoimmunity Lupus Development of spontaneous lupus-like disease in CD48−/− mice or a mixed 129-B6 background [47] Colitis Anti-CD48 blocking mAb ameliorates colitis in the CD45RBhi transfer model; CD48−/− mice show reduced severity of colitis; demonstra…”
CD2 is a Dominant Target for Allogeneic Responses
Bai, Y., Fu, S., Honig, S., Wang, Y., Qin, L., Chen, D., & Bromberg, J. S. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20706.x · Cited by 10 · cited 1×
“Anti-CD244 mAb did not enhance the effects of either anti-CD2 or anti-CD48 [119].”
Cited by
Detection of differentially abundant cell subpopulations in scRNA-seq data
Zhao, J., Jaffe, A., Li, H., Lindenbaum, O., Sefik, E., Jackson, R., Cheng, X., Flavell, R. A., & Kluger, Y. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100293118 · Cited by 154
“Subpopulation DA 1 is more abundant in critical cases and shows elevated expression of activation markers CD48 , CD63 (28, 29).”
BackgroundBat genomes illuminate adaptations to viral tolerance and disease resistance
Morales, A. E., Dong, Y., Brown, T., Baid, K., Kontopoulos, D. G., Gonzalez, V., Huang, Z., Ahmed, A.-W., Bhuinya, A., Hilgers, L., et al. (2025) · Nature · doi:10.1038/s41586-024-08471-0 · Cited by 78
FOXP3 protects conventional human T cells from premature restimulation-induced cell death
Voss, K., Lake, C., Luthers, C. R., Lott, N. M., Dorjbal, B., Arjunaraja, S., Bauman, B. M., Soltis, A. R., Sukumar, G., Dalgard, C. L., et al. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0316-z · Cited by 21
Metadata
- Authors
- McArdel, S. L., Terhorst, C., & Sharpe, A. H.
- Venue
- Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 164
- Pages
- 10-20
- ISSN
- 1521-6616 (ISSN-L)
- OpenAlex
- W2286569941
- Cited by
- 210
- References
- 113
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.